|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 266, Issue 6 2334-H2342, Copyright © 1994 by American Physiological Society
ARTICLES |
Z. Yu, G. A. Quamme and J. H. McNeill
Faculties of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Experimentally, diabetic rat hearts are characterized by diminished responses to beta-adrenergic stimulation. Among the aberrant responses are diminished beta-adrenoceptor number and depressed contractile protein activity. In this study, intracellular Ca2+ concentration ([Ca2+]i) was determined by microfluorescence in response to beta-adrenergic stimulation to understand the basis for the changes in the beta-adrenergic pathway in diabetic myocardium. In quiescent myocytes, isoproterenol caused a decrease in [Ca2+]i, which was blocked by timolol and thapsigargin. This suggests that the beta-agonist-induced [Ca2+]i changes are mediated, in part, by sarcoplasmic reticulum Ca-adenosinetriphosphatase. Diabetic myocytes showed a blunted response to isoproterenol, which was reversed by insulin treatment. In electrically stimulated myocytes, isoproterenol and 8-bromo-adenosine 3',5'-cyclic monophosphate (cAMP) increased [Ca2+]i and contraction in a concentration-dependent manner. Electrically stimulated diabetic myocytes demonstrated a depressed maximum [Ca2+]i response to isoproterenol and 8-bromo-cAMP without a change in sensitivity. These data suggest that in addition to alterations in beta-adrenoceptor function there are postreceptor defects in diabetic myocardium that may impair the regulation of [Ca2+]i in diabetic myocardium.
This article has been cited by other articles:
![]() |
H. K. Saini, O. N. Tripathi, S. Zhang, V. Elimban, and N. S. Dhalla Involvement of Na+/Ca2+ exchanger in catecholamine-induced increase in intracellular calcium in cardiomyocytes Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H373 - H380. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhong, P. J Reiser, and M. A. Matlib Gender differences in myosin heavy chain-{beta} and phosphorylated phospholamban in diabetic rat hearts Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2688 - H2693. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U. Trost, D. D. Belke, W. F. Bluhm, M. Meyer, E. Swanson, and W. H. Dillmann Overexpression of the Sarcoplasmic Reticulum Ca2+-ATPase Improves Myocardial Contractility in Diabetic Cardiomyopathy Diabetes, April 1, 2002; 51(4): 1166 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Netticadan, R. M. Temsah, A. Kent, V. Elimban, and N. S. Dhalla Depressed Levels of Ca2+-Cycling Proteins May Underlie Sarcoplasmic Reticulum Dysfunction in the Diabetic Heart Diabetes, September 1, 2001; 50(9): 2133 - 2138. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishikawa, H. Kajiwara, and S. Kurihara Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2185 - H2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Maltsev, G. J. Ji, A. M. Wobus, B. K. Fleischmann, and J. Hescheler Establishment of ß-Adrenergic Modulation of L-Type Ca2+ Current in the Early Stages of Cardiomyocyte Development Circ. Res., February 5, 1999; 84(2): 136 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tamada, Y. Hattori, H. Houzen, Y. Yamada, I. Sakuma, A. Kitabatake, and M. Kanno Effects of beta -adrenoceptor stimulation on contractility, [Ca2+]i, and Ca2+ current in diabetic rat cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1849 - H1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tosaki and D. K. Das Extracellular Mg++ Manipulation Prevents the Proarrhythmic Activity of Cromakalim in Ischemic/Reperfused Diabetic Hearts J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 309 - 317. [Abstract] [Full Text] |
||||
![]() |
S. Gando, Y. Hattori, Y. Akaishi, J. Nishihira, and M. Kanno Impaired Contractile Response to Beta Adrenoceptor Stimulation in Diabetic Rat Hearts: Alterations in Beta Adrenoceptors-G Protein-Adenylate Cyclase System and Phospholamban Phosphorylation J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 475 - 484. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |